Year archive

RADIOPHARM THERANOSTICS LIMITED — 2023 filings

All 65 regulatory filings released by RADIOPHARM THERANOSTICS LIMITED (RAD) in 2023, sourced directly from the official regulator.

65 Filings

2023 Period

2023 filings (65)

Filing	Released	Lang
2nd Australian site for Nanomab-PDL-1 Phase 1 trial 2 pages 320.8KB Regulatory Filings	2023-12-26	English
Phase 1 Therapeutic NSCLC (Lung Cancer) Trial Opens 4 Jan 2 pages 285.0KB Regulatory Filings	2023-12-21	English
Notification regarding unquoted securities - RAD 5 pages 26.4KB Regulatory Filings	2023-12-21	English
Application for quotation of securities - RAD 6 pages 28.5KB Regulatory Filings	2023-12-14	English
Notice Under Section 708A 1 page 132.9KB Regulatory Filings	2023-12-14	English
Change of Director's Interest Notice x5 15 pages 492.0KB Regulatory Filings	2023-12-14	English
Completion of Entitlement Offer 2 pages 170.6KB Regulatory Filings	2023-12-07	English
Application for quotation of securities - RAD 6 pages 28.0KB Regulatory Filings	2023-12-07	English
Change of Director's Interest Notice - PH IT RC 9 pages 333.9KB Regulatory Filings	2023-12-06	English
Notification regarding unquoted securities - RAD 7 pages 30.4KB Regulatory Filings	2023-11-30	English
Application for quotation of securities - RAD 7 pages 28.5KB Regulatory Filings	2023-11-23	English
Amended Constitution 55 pages 1.0MB Regulatory Filings	2023-11-21	English
Entitlement Offer closing date extended to 1 December 2023 2 pages 150.0KB Regulatory Filings	2023-11-20	English
Update - Proposed issue of securities - RAD 6 pages 31.4KB Regulatory Filings	2023-11-20	English
Radiopharm receives $4.85M R&D tax incentive 1 page Regulatory Filings	2023-11-20	English
Presentation to Annual General Meeting 16 pages 1.0MB Regulatory Filings	2023-11-15	English
Results of Annual General Meeting 2 pages 129.0KB Regulatory Filings	2023-11-15	English
Notification of Release of Shares from Escrow 1 pag Regulatory Filings	2023-11-15	English
Bell Potter Healthcare Conference Presentation 25 pages 2.1MB Regulatory Filings	2023-11-14	English
Entitlement Offer Documents 46 pages 5.6MB Regulatory Filings	2023-11-07	English
Entitlement Offer to raise approximately $10 million 4 pages 248.4KB Regulatory Filings	2023-10-30	English
Investor Presentation - Entitlement Offer 29 pages 2.1MB Regulatory Filings	2023-10-30	English
Proposed issue of securities - RAD 6 pages 31.8KB Regulatory Filings	2023-10-30	English
Investor webinar 1 page 139.6KB Regulatory Filings	2023-10-30	English
Proposed issue of securities - RAD 5 pages 27.1KB Regulatory Filings	2023-10-30	English
Entitlement Offer cleansing notice under section 708AA 3 pages 226.2KB Regulatory Filings	2023-10-30	English
Quarterly Activities/Appendix 4C Cash Flow Report 14 pages 1.6MB Regulatory Filings	2023-10-30	English
Notice of Annual General Meeting/Proxy Form 36 pages 718.3KB Regulatory Filings	2023-10-17	English
FDA green light for diagnostic Phase 1 pancreatic trial 2 pages 191.5KB Regulatory Filings	2023-10-16	English
RAD receives approval for Phase 1 therapeutic study of NSCLC 2 pages 142.7KB Regulatory Filings	2023-10-08	English
Annual Report to shareholders 99 pages 2.1MB Regulatory Filings	2023-09-27	English
Corporate Governance Statement 7 pages 211.3KB Regulatory Filings	2023-09-27	English
Appendix 4G 12 pages 344.5KB Regulatory Filings	2023-09-27	English
ESG Report 10 pages 462.6KB Regulatory Filings	2023-09-27	English
Appendix 4E and FY23 Financial Report 96 pages 2.0MB Regulatory Filings	2023-08-30	English
TerThera Terbium-161 isotope supply agreement expanded 3 pages 234.0KB Regulatory Filings	2023-08-23	English
EGM Presentation 7 pages 412.6KB Regulatory Filings	2023-08-17	English
Results of Meeting 2 pages 127.7KB Regulatory Filings	2023-08-17	English
Change of Director's Interest Notice IT 3 pages 209.6KB Regulatory Filings	2023-08-07	English
Quarterly Activities/Appendix 4C Cash Flow Report 11 pages 1.6MB Regulatory Filings	2023-07-30	English
Dr Sherin Al-Safadi appointed VP Medical & Corporate Affairs 2 pages 140.7KB Regulatory Filings	2023-07-23	English
Notice of Extraordinary General Meeting/Proxy Form 12 pages 485.1KB Regulatory Filings	2023-07-19	English
Notification regarding unquoted securities - RAD 6 pages 28.3KB Regulatory Filings	2023-06-29	English
Notification of cessation of securities - RAD 4 pages 24.1KB Regulatory Filings	2023-06-29	English
Pivalate educational webinar 14 June 2023 2 pages 143.6KB Regulatory Filings	2023-06-12	English
FDA Pre-IND meeting supports an IND application for RAD 101 2 pages 140.7KB Regulatory Filings	2023-05-28	English
RAD 301 receives FDA Orphan Drug Designation 2 pages 242.5KB Regulatory Filings	2023-05-08	English
Application for quotation of securities - RAD 7 pages 29.5KB Regulatory Filings	2023-04-27	English
Quarterly Activities/Appendix 4C Cash Flow Report 12 pages 1.4MB Regulatory Filings	2023-04-26	English
Agreement with TerThera to supply Terbium-161 isotope 3 pages 242.2KB Regulatory Filings	2023-04-16	English
Radiopharm to participate in Jefferies Radiopharma Summit 2 pages 156.9KB Regulatory Filings	2023-03-27	English
Radiopharm Receives $1.56M R&D Tax Incentive 1 page Regulatory Filings	2023-03-27	English
RAD and GenesisCare to Develop Novel Radiopharmaceuticals 2 pages 203.8KB Regulatory Filings	2023-03-26	English
RAD to present at virtual healthcare conference 1 p Regulatory Filings	2023-03-16	English
Application for quotation of securities - RAD 6 pages 28.1KB Regulatory Filings	2023-03-05	English
Notice Under Section 708A 1 page 129.4KB Regulatory Filings	2023-03-05	English
Proposed issue of securities - RAD 5 pages 27.7KB Regulatory Filings	2023-03-02	English
Radiopharm to acquire Pharma15 Corporation 3 pages 158.4KB Regulatory Filings	2023-03-02	English
Dr Ken Herrmann appointed to RAD Scientific Advisory Board 1 Regulatory Filings	2023-03-02	English
Appendix 4D and Half Year Report 42 pages 1.6MB Regulatory Filings	2023-02-27	English
Radiopharm Theranostics initiates process for Nasdaq listing 2 pages 216.0KB Regulatory Filings	2023-02-13	English
Notification regarding unquoted securities - RAD 6 pages 28.0KB Regulatory Filings	2023-02-13	English
Quarterly Activities/Appendix 4C Cash Flow Report 12 pages 1.4MB Regulatory Filings	2023-01-30	English
Dr. Rama Abu Shmeis appointed Senior VP, CMC 2 pages 139.8KB Regulatory Filings	2023-01-10	English
Change in substantial holding - NT 2 pages 768.9KB Regulatory Filings	2023-01-05	English